Empagliflozin α-isomer NEW

$0.00 10mg

$0.00 30mg

$0.00 100mg

Min. Order10mg
Purity98%+
Cas No1620758-33-9
Supply Ability10000000
Update time2024-12-13

Moxin Chemicals

1YR

China

Since2022-11-29

AddressRoom 005-01, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake

show less show more

Chemical Properties

Product Name	Empagliflozin α-isomer
CAS No	1620758-33-9
EC-No
Min. Order	10mg
Purity	98%+
Supply Ability	10000000
Release date	2024/12/13

Empagliflozin α-isomer

Empagliflozin impurities refer to the unintended chemical components produced during the manufacturing process of empagliflozin, a hypoglycemic drug. These impurities may include various compounds with different structures.

Among them, Empagliflozin α-isomer is a relatively common type of impurity with specific chemical structure and properties. In addition, there are other types of empagliflozin impurities, such as Empagliflozin Impurity Z12, etc. The specific structures and properties of these impurities may vary depending on the production process and conditions.

The presence of empagliflozin impurities may have an important impact on the efficacy and safety of the drug. Therefore, in drug research and development and production processes, it is necessary to strictly control and analyze empagliflozin impurities to ensure the quality and safety of the drug.

All of our products include a complete set of structural confirmation maps. Such as COA, H-NMR,MASS,HPLC,UV,IR。The default HPLC purity of our products is not less than 95%. Particularly unstable products have a purity of no less than 90% and will be communicated to the customer in advance. we can also provide TGA,Q-NMR,C-NMR and so on。

show less show more

Company Profile Introduction

1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability. 2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs. 3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects. 4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes. 5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.